GlassScriptPhysician profile
Terry A Melvin
NPI 1720191604
$7,149.13
in general payments reported to CMS, 2019-2025
56 companies · $1,448 in 2025
The $1,448 reported for 2025 was more than what 93% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $675 · 2021: $1,339 · 2022: $1,153 · 2023: $786 · 2024: $1,269 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,473 · Education: $30.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,472.78 |
| Education | $30.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $797.16 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $676.71 | 2020-2025 | Freestyle Libre 3 |
| Abbvie INC. | $644.48 | 2019-2025 | |
| Novo Nordisk INC | $545.31 | 2021-2025 | Ozempic, Rybelsus |
| Corcept Therapeutics | $379.47 | 2019-2024 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $339.62 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $320.92 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Novartis Pharmaceuticals Corporation | $308.00 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $266.79 | 2019-2022 | |
| Mannkind Corporation | $223.47 | 2019-2025 | |
| Medtronic, INC. | $192.12 | 2022-2023 | Minimed 780g |
| Tandem Diabetes Care, INC. | $145.47 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $141.79 | 2019-2024 | Repatha, Prolia, Evenity |
| Amarin Pharma, INC. | $139.75 | 2020-2021 | |
| Silk Road Medical, INC. | $136.77 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Melvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.